UBS Group’s Acruence Active Hedge US Equity ETF XVOL Stock Holding History

UBS Group’s Portfolio XVOL Stock Details XVOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-359	Closed	-$8.02K	–	11120
2026 Q1	$8.02K	Buy	+359	New	+$8.34K	﹤0.01%	8529
2024 Q4	–	Sell	-705	Closed	-$15.4K	–	10488
2024 Q3	$15.4K	Buy	+705	New	+$14.9K	﹤0.01%	7514
2024 Q2	–	Sell	-78	Closed	-$1.62K	–	10199
2024 Q1	$1.62K	Buy	+78	New	+$1.49K	﹤0.01%	8099
2023 Q3	–	Sell	-2	Closed	-$37	–	10036
2023 Q2	$37	Buy	+2	New	+$36	﹤0.01%	8635
2022 Q4	–	Sell	-908	Closed	-$15K	–	11210
2022 Q3	$15K	Buy	908 +1	+0.1%	+$19	﹤0.01%	7833
2022 Q2	$16K	Buy	907 +312	+52%	+$6.02K	﹤0.01%	7216
2022 Q1	$13K	Buy	595 +578	+3,400%	+$12.1K	﹤0.01%	8084
2021 Q4	$0	Sell	17 -53	-76%	-$1.16K	﹤0.01%	10782
2021 Q3	$1K	Buy	+70	New	+$1.48K	﹤0.01%	9263

Other funds holding XVOL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's XVOL Position: Q2 2026 in Review

UBS Group sold out of Acruence Active Hedge US Equity ETF (XVOL) in Q2 2026, closing a stake of 359 shares — an estimated $8.02K sold.

UBS Group first reported a position in XVOL in Q3 2021 and held it in 9 quarters. The position peaked at $16K in Q2 2022. 1 fund tracked by Wall St. Rank holds XVOL as of Q2 2026.

UBS Group reported no remaining Acruence Active Hedge US Equity ETF position as of Q2 2026 after selling out during the quarter.
UBS Group sold 359 Acruence Active Hedge US Equity ETF shares in Q2 2026, an estimated $8.02K.
UBS Group first reported a position in Acruence Active Hedge US Equity ETF in Q3 2021 and held it in 9 quarters.
UBS Group's Acruence Active Hedge US Equity ETF position peaked at $16K in Q2 2022.
1 fund tracked by Wall St. Rank held Acruence Active Hedge US Equity ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.